Ascitic growth of a t cell lymphoma in mice alters the humoral and cellular immune response to exogenous antigens

Tumor Biology

Volumn 18, Issue 2, 1997, Pages 104-112

  Parajuli, Prahlad ^a,b   Singh, Sukh Mahendra ^a,b  

^a UNIVERSITY OF DELHI   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Antigen presentation; Dalton s lymphoma; Delayed type hypersensitivity response; FK565; Humoral; Immune response

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; HEPTANOYL GAMMA DEXTRO GLUTAMYL 2,6 DIAMINOPIMELOYL DEXTRO ALANINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; ASCITES TUMOR; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T CELL LYMPHOMA;

EID: 0031023955     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1159/000218021     Document Type: Article

References (17)

1. Locfflcr CM, Smyth MJ, Longo DL, Kopp WC, Harvey LK, Tribble HR, Tase JE, Urba WJ, Leonard AS, Young HA, Ochoa C: Immunoregu-lation of cancer-bearing hosts, Down-regulation of gene expression and cytotoxic function in CD8+ T Cells, J Immunol 1992; 149:949-956.
2. Christensen ND, Krcidcr JW, Ho-retsky RL: Suppressor lymphokine produced by rat T cells in response to syngeneic mammary adenocarcinoma 13762A, Cancer Res 1988;48: 943-949.
3. Deckers PJ, Davis RC, Parker GA, Mannick JA: The effect of tumor size on concomitant tumor immunity, Cancer Res 1973;33:33-38.
4. Elgert KD, Farrar WL: Suppressor cell activity in tumor-bearing mice, I, Dualistic inhibition by suppressor T lymphocytes and macrophages, J Immunol 1978;120:1345-1353.
5. Gregorian SK, Battisto JR: Immunosuppression in murine renal cell carcinoma, II, Identification of responsible lymphoid cell phenotypes and examination of elimination of suppression, Cancer Immunol Im-munother 1990;31:335-341.
6. Lcjcune P, Legadec P, Onier N, Pinard D, Ohshima H, Jcannin J-F: Nitric oxide involvement in tumor-induced immunosuppression, J Immunol 1994:152:5077-5083.
7. Pommier GJ, Garrouste FL, Bette-tini D, Culouscou JM, Remacle-Bonnet MM: In vivo delayed rejection of tumors and inhibition of de-layed-type hypersensitivity by HT-29 human colonic adenocarcinoma cell line, Cancer Immunol Immu-nother 1987;24:225-230.
8. Udaychander M, Meenakshi A, Mu-thiah R, Sivanandham R: Tumor targeting potential of liposomes encapsulating Ga-67 and antibody to Dalton’s lymphoma associated antigen (anti-DLAA), Int J Radiat Oncol Biol Phys 1987; 13:1713-1719.
9. Kumar A, Singh SM, Parajuli P: Modulatory effect of Dalton’s lymphoma cells on the production of reactive nitrogen intermediates, interleukin-1 and tumor necrosis factor by murine peritoneal macrophages, Neoplasma 1994:41:363-369.
10. Parajuli P, Singh SM, Kumar A: Effect of cisplatin and FK565 on the activation of tumor-associated and bone marrow-derived macrophages by Dalton’s lymphoma, Int J Immu-nopharmacol 1995;17:1-7.
11. Parajuli P, Singh SM: Modulation of hemopoiesis in normal and tumor-bearing mice on in vivo administration of FK565, Int J Immunopathol Pharmacol 1995;8:241-247.
12. Talmadge JE, Lenz B, Schneider M, Phillips M, Long C: Immunomodulatory and therapeutic properties of FK565 in mice, Cancer Immunol Immunother 1989:28:93-100.
13. Cunningham AJ, Szenberg A: Further improvements in the plaque technique for detecting single antibody forming cell, Immunology 1968;14:599-603.
14. Sodhi A, Gupta P: Study on pinocy-tosis and antigen presentation by murine peritoneal macrophages to T cells in vitro after cisplatin treatment, Arch Immunol Ther Exp 1988;36:315-323.
15. Phanuphak P, Moorhead JW, daman HN: Tolerance and contact sensitivity to DNFB in mice, I, In vivo detection by car swelling and correlation with in vitro cell stimulation, J Immunol 1974:112:115-123.
16. Tada T, Ohzeki S, Utsumi K, Takin-chi H, Muramatsu M, Li X-F, Shimizu J, Fujiwara H, Hamaoka T: Transforming growth factor-B-in-duced inhibition of T cell function, Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state, J Immuncl 1991;146:1077-1082.
17. Tada T, Sano H, Sato S, Shima J, Fujiwara H, Hamaoka T: Immune dysfunction expressed selectively on L3T4* T cells in the tumor-bearing state, J Leukoc Biol 1990;47:149- 157.